Valuation: Pfizer Inc.

Capitalization 15TCr 13TCr 12TCr 11TCr 21TCr 13,89600Cr 22TCr 1,40200Cr 56TCr 6,65800Cr 57TCr 56TCr 23,87300Cr P/E ratio 2026 *
12.4x
P/E ratio 2027 * 13x
Enterprise value 19TCr 17TCr 15TCr 15TCr 27TCr 17,76900Cr 28TCr 1,79300Cr 72TCr 8,51300Cr 73TCr 71TCr 30,52700Cr EV / Sales 2026 *
3.16x
EV / Sales 2027 * 3.21x
Free-Float
59.04%
Yield 2026 *
6.61%
Yield 2027 * 6.64%
1 day-0.13%
1 week-1.81%
Current month-3.76%
1 month+0.45%
3 months+2.23%
6 months+6.95%
Current year+6.87%
1 week 26.2
Extreme 26.2
27.61
1 month 26.2
Extreme 26.2
27.94
Current year 24.83
Extreme 24.83
27.94
1 year 20.92
Extreme 20.915
27.94
3 years 20.92
Extreme 20.915
42.22
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 61 02/05/2022
Chief Tech/Sci/R&D Officer - 24/02/2025
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.04%-1.81%+2.58%-35.33% 15TCr
-2.02%-3.79%+5.76%+208.78% 88TCr
-2.31%-1.58%+45.12%+55.58% 58TCr
-1.63%+3.41%+9.84%+48.89% 41TCr
-3.34%-7.41%+12.26%+25.53% 36TCr
-1.73%-6.41%+20.93%+35.41% 30TCr
-2.27%-6.44%+22.75%+54.13% 30TCr
-3.50%-2.71%+24.55%+8.60% 29TCr
-3.08%-3.09%+16.12%+56.55% 20TCr
-2.08%+0.95%+25.73%+79.03% 18TCr
Average -1.17%-1.50%+18.56%+53.72% 36.51TCr
Weighted average by Cap. -1.22%-1.65%+18.66%+80.68%

Financials

2026 *2027 *
Net sales 6.12TCr 5.29TCr 4.79TCr 4.6TCr 8.39TCr 5,61700Cr 8.76TCr 57TCr 23TCr 2,69100Cr 23TCr 22TCr 9,65000Cr 5.89TCr 5.1TCr 4.61TCr 4.43TCr 8.08TCr 5,41200Cr 8.44TCr 55TCr 22TCr 2,59300Cr 22TCr 22TCr 9,29800Cr
Net income 1.21TCr 1.04TCr 944.18Cr 906.48Cr 1.65TCr 1,10700Cr 1.73TCr 11TCr 4.46TCr 53TCr 4.53TCr 4.43TCr 1,90200Cr 1.17TCr 1.01TCr 913.3Cr 876.83Cr 1.6TCr 1,07100Cr 1.67TCr 11TCr 4.32TCr 51TCr 4.38TCr 4.28TCr 1,84000Cr
Net Debt 4.22TCr 3.65TCr 3.3TCr 3.17TCr 5.78TCr 3,87300Cr 6.04TCr 39TCr 16TCr 1,85600Cr 16TCr 15TCr 6,65500Cr 3.8TCr 3.28TCr 2.97TCr 2.85TCr 5.2TCr 3,48500Cr 5.43TCr 35TCr 14TCr 1,67000Cr 14TCr 14TCr 5,98800Cr
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
75,000
Date Price Change Volume
05/26/05 26.61 $ -0.04% 3,89,08,616
04/26/04 26.62 $ +0.15% 3,08,93,515
03/26/03 26.58 $ -2.49% 4,14,86,090
02/26/02 27.26 $ -1.41% 4,13,21,689
27/26/27 27.65 $ +2.03% 4,18,79,693
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
26.61USD
Average target price
28.43USD
Spread / Average Target
+6.82%

Quarterly revenue - Rate of surprise